A Study of FDA018-ADC in Patients With Advanced Solid Tumors
A Study of FDA018-ADC in Patients With Advanced Solid Tumors
Active, not recruiting · NCT05174637 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of FDA018-ADC in Patients With Advanced Solid Tumors | Advanced/ Metastatic Solid Tumors | Active, not recruiting | Phase 1 | 2026-01-23 | NCT05174637 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 27 |